Cargando…
Endocan and Erectile Dysfunction
Endothelial dysfunction (ED) occurs early in the development of atherosclerosis. Predictors of vascular risk including obesity, hyperlipidemia, metabolic syndrome, diabetes mellitus, and hypertension are associated with both vascular endothelial and ED. Endocan is a novel marker of endothelial dysfu...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909267/ https://www.ncbi.nlm.nih.gov/pubmed/31829075 http://dx.doi.org/10.1177/1557988319893889 |
_version_ | 1783478923253776384 |
---|---|
author | Balta, Sevket Mikhailidis, Dimitri P. |
author_facet | Balta, Sevket Mikhailidis, Dimitri P. |
author_sort | Balta, Sevket |
collection | PubMed |
description | Endothelial dysfunction (ED) occurs early in the development of atherosclerosis. Predictors of vascular risk including obesity, hyperlipidemia, metabolic syndrome, diabetes mellitus, and hypertension are associated with both vascular endothelial and ED. Endocan is a novel marker of endothelial dysfunction, inflammation, and atherosclerosis. Raised endocan levels (usually measured by ELISA assays) were reported in some cardiovascular diseases and related conditions. Increased endocan levels may represent the endothelial and inflammatory components of the pathogenesis of ED and may, therefore, prove useful in clinical practice. |
format | Online Article Text |
id | pubmed-6909267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-69092672019-12-18 Endocan and Erectile Dysfunction Balta, Sevket Mikhailidis, Dimitri P. Am J Mens Health Research Briefs Endothelial dysfunction (ED) occurs early in the development of atherosclerosis. Predictors of vascular risk including obesity, hyperlipidemia, metabolic syndrome, diabetes mellitus, and hypertension are associated with both vascular endothelial and ED. Endocan is a novel marker of endothelial dysfunction, inflammation, and atherosclerosis. Raised endocan levels (usually measured by ELISA assays) were reported in some cardiovascular diseases and related conditions. Increased endocan levels may represent the endothelial and inflammatory components of the pathogenesis of ED and may, therefore, prove useful in clinical practice. SAGE Publications 2019-12-12 /pmc/articles/PMC6909267/ /pubmed/31829075 http://dx.doi.org/10.1177/1557988319893889 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research Briefs Balta, Sevket Mikhailidis, Dimitri P. Endocan and Erectile Dysfunction |
title | Endocan and Erectile Dysfunction |
title_full | Endocan and Erectile Dysfunction |
title_fullStr | Endocan and Erectile Dysfunction |
title_full_unstemmed | Endocan and Erectile Dysfunction |
title_short | Endocan and Erectile Dysfunction |
title_sort | endocan and erectile dysfunction |
topic | Research Briefs |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909267/ https://www.ncbi.nlm.nih.gov/pubmed/31829075 http://dx.doi.org/10.1177/1557988319893889 |
work_keys_str_mv | AT baltasevket endocananderectiledysfunction AT mikhailidisdimitrip endocananderectiledysfunction |